 Cervicovaginal microflora pregnancy outcome results double-blind placebo-controlled trial erythromycin treatment Available information instances preterm birth premature rupture membranes unrecognized infection inflammation uterine segment decidua fetal membranes Various cervicovaginal microorganisms sites Many microorganisms factors fetal membranes release prostaglandins study presence various genital tract microflora bacterial conditions women double-blind placebo-controlled trial short-course erythromycin treatment weeks gestation preterm birth Demographic obstetric microbiologic parameters Premature rupture membranes women erythromycin versus placebo Preterm premature rupture membranes patients erythromycin versus placebo Erythromycin treatment occurrence premature rupture membranes women positive Chlamydia trachomatis infection Logistic regression analysis trachomatis odds vaginal wash phospholipase odds prior preterm birth odds increased risk preterm birth Bacterial vaginosis Mycoplasma hominis Ureaplasma increased risk preterm birth preterm rupture membranes findings role genital tract microflora preterm birth premature rupture Large treatment trials specific infections conditions preterm birth premature rupture membranes value antimicrobial treatments prevention microbial-associated preterm birth